Revised Outcome of the Board Meeting pertaining to clarification for wrong Submission of Limited Review Report instead of Audit Report for Financial Results for the Quarter and Year Ended ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adline Chem Lab is re-filing its March 31, 2025 financial results because the original May 9, 2025 submission accidentally attached a Limited Review Report instead of the required Audit Report. The company confirms the financial numbers themselves are unchanged and the statutory auditors have now issued an unmodified (clean) audit opinion on the full-year results. For FY25, the company reported essentially zero revenue from operations, total income of just Rs. 24.89 lakhs (entirely from a one-time gain on modification of financial liabilities), total expenses of Rs. 45.46 lakhs, and a loss after tax of Rs. 13.22 lakhs, compared to a loss of Rs. 27.18 lakhs in the prior year. The auditor separately flagged a related-party transaction with group entity Vivanza Lifescience Private Limited that lacked prior shareholder approval, though this did not modify the audit opinion.
The correction is procedural only and should not change fundamentals, but underlying results remain weak with negative net worth, negative operating cash flows, and negligible operating revenue. Shareholders should note the flagged related-party compliance issue and the company's continued reliance on one-time accounting adjustments to show any profit.